In this study, we tried to evaluate the effects of a new meal replacement on obesity and metabolic syndrome in mice, using clinical markers including body weight, glucose level, insulin level, HOMA-IR, lipid level, epididymal fat pad weight, liver weight, and gene expressions related to inflammation and insulin receptor. Here, INS is linked to metabolic syndrome.